Andersons pediatric cardiology 1899

Homemonitoringprogramreducesmortalityin
high-risksociodemographicsingle-ventricle
patients.PediatrCardiol.2016;37(8):1575–
1580.
7.AndersonJB,BeekmanRH3rd,KuglerJD,et
al.Improvementininterstagesurvivalina
nationalpediatriccardiologylearningnetwork.
CircCardiovascQualOutcomes.
2015;8(4):428–436.
8.GhanayemNS,HoffmanGM,MussattoKA,et
al.Homesurveillanceprogramprevents
interstagemortalityaftertheNorwood
procedure.JThoracCardiovascSurg.
2003;126(5):1367–1377.
9.PetitCJ,FraserCD,MattamalR,etal.The
impactofadedicatedsingle-ventriclehomemonitoringprogramoninterstagesomatic
growth,interstageattrition,and1-yearsurvival.
JThoracCardiovascSurg.2011;142(6):1358–
1366.
10.HehirDA,RuddN,SlickerJ,etal.Normal
interstagegrowthafterthenorwoodoperation
associatedwithinterstagehomemonitoring.
PediatrCardiol.2012;33(8):1315–1322.
11.GhanayemNS,TweddellJS,HoffmanGM,
MussattoK,JaquissRD.Optimaltimingofthe
secondstageofpalliationforhypoplasticleft


heartsyndromefacilitatedthroughhome
monitoring,andtheresultsofearly
cavopulmonaryanastomosis.CardiolYoung.

2006;16(suppl1):61–66.
12.JaquissRD,GhanayemNS,HoffmanGM,etal.
Earlycavopulmonaryanastomosisinveryyoung
infantsaftertheNorwoodprocedure:impacton
oxygenation,resourceutilization,andmortality.
JThoracCardiovascSurg.2004;127(4):982–
989.
13.MeakinsL,RayL,HegadorenK,RogersLG,
RempelGR.Parentalvigilanceincaringfor
theirchildrenwithhypoplasticleftheart
syndrome.PediatrNurs.2015;41(1):31–41[50].
14.AndersonJB,BeekmanRH3rd,KuglerJD,etal.
Useofalearningnetworktoimprovevariation
ininterstageweightgainaftertheNorwood
operation.CongenitHeartDis.2014;9(6):512–
520.
15.ClaussSB,AndersonJB,LannonC,etal.Quality
improvementthroughcollaboration:thenational
pediatricqualityimprovementcollaborative
initiative.CurrOpinPediatr.2015;27(5):555–
562.
16.TheofilouP.Communicationamonghealthcare
professionals:acentralfactorinpatient
outcome.JNursingCare.2011;1:101.


17.SiehrSL,MaedaK,ConnollyAA,etal.Mitral
stenosisandaorticAtresia–Ariskfactorfor
mortalityafterthemodifiedNorwoodoperation
inhypoplasticleftheartsyndrome.AnnThorac

Surg.2016;101(1):162–167.
18.GlatzJA,FedderlyRT,GhanayemNS,Tweddell
JS.Impactofmitralstenosisandaorticatresia
onsurvivalinhypoplasticleftheartsyndrome.
AnnThoracSurg.2008;85(6):2057–2062.
19.GaynorJW,MahleWT,CohenMI,etal.Risk
factorsformortalityaftertheNorwood
procedure.EurJCardiothoracSurg.
2002;22(1):82–89.
20.MahleWT,SprayTL,GaynorJW,ClarkBJ3rd.
Unexpecteddeathafterreconstructivesurgery
forhypoplasticleftheartsyndrome.AnnThorac
Surg.2001;71(1):61–65.
21.GhanayemNS,AllenKR,TabbuttS,etal.
InterstagemortalityaftertheNorwood
procedure:resultsofthemulticentersingle
ventriclereconstructiontrial.JThorac
CardiovascSurg.2012;144(4):896–906.
22.CrossRR,HarahshehAS,McCarterR,Martin
GR,NationalPediatricCardiologyQuality
ImprovementC.Identifiedmortalityriskfactors
associatedwithpresentation,initial
hospitalisation,andinterstageperiodforthe